MycoBiomDB – Record Details (MyCo_5993)

Biomarker Record Details

Database ID: MyCo_5993
DB IDMyCo_5993
TitleCandida biomarkers in patients with candidaemia and bacteraemia
Year2015
PMID25900160
Fungal Diseases involvedCandidemia
Associated Medical ConditionNone
GenusCandida
Speciesparapsilosis
OrganismCandida parapsilosis
Ethical StatementThe study was approved by the local ethics committee (CEIC-A1, ref. 350/12) and the relevant Spanish authorities [Agencia Espan ˜ ola del Medicamento y Productos Sanitarios, AEMPS (Spanish Agency for Medicines and Health Care Products)]. The use of stored sera was authorized with a waiver of informed consent by the ethics committee.
Site of InfectionNone
Opportunistic invasiveNone
Sample typeBody fluid
Sample sourceSerum
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameMN
Biomarker Full NameMannan
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationSpain
CohortHere studied serum samples from adult patients with candidaemia (n= 31)
Cohort No.31
Age GroupNone
P ValueNone
Sensitivity64.3
Specificity95.7
Positive Predictive Value90
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismNone
TechniqueImmunological assay
Analysis MethodPlatelia Candida Ag Plus assay
ELISA kitsCAGTA Immunofluorescence test Kit (Vircell Microbiologist S.L., Granada, Spain), Platelia Candida Ag Plus assay kit (Bio-Rad, Marnes-la-Coquette, France).
Assay DataFDA- Fungitell®, Cape Cod International, Inc.; Falmounth, MA, USA
Validation Techniques usedFDA Approved-Fungitell assay, Immunofluorescence test, Platelia Candida Ag Plus assay
Up Regulation Down RegulationPositive
Sequence DataNone
External LinkNone